Related Experiment Video
Updated: Aug 26, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Pharmacokinetics and bioavailability of pyridinol carbamate in humans
Abstract:
The pharmacokinetics of two pyridinol carbamate formulations were studied after a single oral administration in 10 healthy volunteers. An open one-compartment model described the evolution of plasma concentrations as a function of time. Pyridinol carbamate was rapidly absorbed (mean lag time from 0.36 to 0.38 hr). Its elimination half-life ranged from 3.3 to 7.9 hr. The two formulations were bioequivalent.
Related Concept Videos
Bioavailability: Overview
Bioavailability: Overview
Bioavailability: Influencing Factors
Measurement of Bioavailability: Pharmacokinetic Methods
Measurement of Bioavailability: Pharmacodynamic Methods
Modified-Release Drug Delivery Systems: Bioavailability

